Stay updated on HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial

Sign up to get notified when there's something new on the HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Page revision updated from v3.2.0 to v3.3.2; no study details, eligibility criteria, locations, or contacts were affected.
    Difference
    0.1%
    Check dated 2025-11-25T13:39:04.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Removed the site-wide notice about government funding and operating status. The page now displays the study details without that banner.
    Difference
    0.4%
    Check dated 2025-11-18T07:22:01.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    No additions or deletions were detected; the study details, eligibility criteria, and contact information appear unchanged.
    Difference
    0.4%
    Check dated 2025-10-27T20:52:42.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Core content updated to v3.2.0 with a new government funding operating-status notice for NIH Clinical Center; previous v3.1.0 deletion removed the old version tag.
    Difference
    3%
    Check dated 2025-10-06T07:16:34.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Upgrade from Revision v3.0.2 to v3.1.0 with added contact details (phone ext and email).
    Difference
    0.1%
    Check dated 2025-09-29T03:40:33.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2, and the Back to Top element was removed. This reflects minor UI/metadata changes with no impact on core content or critical data.
    Difference
    0.2%
    Check dated 2025-09-14T21:43:54.000Z thumbnail image

Stay in the know with updates to HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial page.